The future is 'PARP' - Phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer
暂无分享,去创建一个
A. Tutt | H. Earl | N. Loman | J. Garber | R. Schmutzler | M. Robson | J. Carmichael | M. Friedlander | C. Liedtke | S. Domchek | A. Wardley | B. Arun | J. Weitzel | M. Audeh | M. Wickens | G. Mitchell